Chemagis Ltd.

Patent No. 7,615,632 Issued on Nov. 10, Assigned to Chemagis for Crystalline Forms (Israeli Inventors)
US Fed News Service, Including US State News; 11/11/2009; 382 words; ...temozolomide. The inventors were issued U.S. Patent No. 7,615,632 on Nov. 10. The patent has been assigned to Chemagis Ltd., Bnei Brak, Israel. According to the abstract released by the U.S. Patent & Trademark Office: "Disclosed...

Publication No. WO/2009/133556 Published on Nov. 5, Assigned to Chemis for Cisatracurium Derivative, Preparation (Israeli Inventors)
US Fed News Service, Including US State News; 11/7/2009; 385 words; ...Israel, have developed a cisatracurium derivatives, preparation and uses thereof. The patent has been assigned to Chemagis Ltd., Bnei Brak, Israel. According to an abstract posted by the World Intellectual Property Organization: "The present...

India : Perrigo acquires 85% in Vedants Drugs.
TendersInfo; 8/24/2009; 850 words; ...operations, employing about 50 people. Under a division called Chemagis, Perrigo develops, manufactures and markets complex chemicals...United Kingdom and Mexico. Copyright : Euclid Infotech Pvt. Ltd. Provided by Syndigate.info an Albawaba.com company

WIPO: Inventors in Israel Develop (1R,1'R)-Atracurium Salts Separation Process
US Fed News Service, Including US State News; 2/13/2009; 360 words; ...of Israel, have developed a (1r,1'r)-atracurium salts separation process. The patent has been assigned to Chemagis Ltd., Bnei Brak, Israel. According to an abstract posted by the World Intellectual Property Organization, the present...

WIPO: Inventor in Israel Develops Atracurium Salts Separation Process
US Fed News Service, Including US State News; 10/17/2008; 428 words; ...invention carries International Patent Publication No. WO/2008/107887 on Sept. 12. The patent has been assigned to Chemagis Ltd., Bnei Brak, Istrael. The original patent was filed in Israel under application No. PCT/IL2008/000289 on March...